SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-22-017608
Filing Date
2022-07-22
Accepted
2022-07-22 16:15:49
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dffn20220721_424b5.htm 424B5 427840
2 dffn20200924_s3img001.jpg GRAPHIC 8812
3 dffn20220721_424b5img001.jpg GRAPHIC 7284
4 dffn20220721_424b5img002.jpg GRAPHIC 7624
  Complete submission text file 0001437749-22-017608.txt   462246
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-249057 | Film No.: 221100109
SIC: 2834 Pharmaceutical Preparations